These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6133644)

  • 1. A review of long-term beta-blocker trials in survivors of myocardial infarction.
    May GS
    Circulation; 1983 Jun; 67(6 Pt 2):I46-9. PubMed ID: 6133644
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of beta-blocker therapy on recurrent nonfatal myocardial infarction.
    Furberg CD; Bell RL
    Circulation; 1983 Jun; 67(6 Pt 2):I83-5. PubMed ID: 6133649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
    Halawa B; Mazurek W
    Wiad Lek; 1986 Jan; 39(1):25-30. PubMed ID: 2872756
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-adrenergic blockade after myocardial infarction: clinical and public health implications of the reported beta-blocker clinical trials.
    Friedewald WT
    Circulation; 1983 Jun; 67(6 Pt 2):I110-1. PubMed ID: 6133641
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?
    Baber NS; Lewis JA
    Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Heart Lung; 1984 Jul; 13(4):366-71. PubMed ID: 6145686
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of acute-phase beta-blocker trials in patients with myocardial infarction.
    May GS
    Circulation; 1983 Jun; 67(6 Pt 2):I21-5. PubMed ID: 6133643
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration.
    Decorde P
    Pharmatherapeutica; 1984; 3(8):515-25. PubMed ID: 6142464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secondary prevention following myocardial infarction--results of long-term studies].
    Berndt H
    Z Arztl Fortbild (Jena); 1983; 77(2):52-8. PubMed ID: 6132502
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of beta-blockers in the treatment of patients after infarction.
    Pratt CM; Young JB; Roberts R
    Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of time-dependent measures to estimate benefits of beta-blockers after myocardial infarction.
    Levy AR; Tamblyn RM; Abrahamowicz M; McLeod PJ; Fitchett D
    Pharmacoepidemiol Drug Saf; 2004 Sep; 13(9):623-31. PubMed ID: 15362086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved prognosis during long-term treatment with beta-blockers after myocardial infarction: analysis of randomized trials and pooling of results.
    Bassan MM; Shalev O; Eliakim A
    Heart Lung; 1984 Mar; 13(2):164-8. PubMed ID: 6142030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
    Tomov I
    Vutr Boles; 1984; 23(3):16-25. PubMed ID: 6147044
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta blocking agents in post myocardial infarction patients.
    Campbell RW; Bourke J
    Eur Heart J; 1986 May; 7 Suppl A():119-21. PubMed ID: 2873038
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction.
    Heller DA; Ahern FM; Kozak M
    Am Heart J; 2000 Oct; 140(4):663-71. PubMed ID: 11011343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention of myocardial infarct with anti-arrhythmia drugs and beta receptor blockaders].
    Mösslacher H
    Wien Med Wochenschr; 1984 Dec; 134(23-24):566-72. PubMed ID: 6152091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prevention after myocardial infarction: facts and fallacies.
    Taylor SH
    J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S914-21. PubMed ID: 6084149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can beta-blocker use lower mortality and improve myocardial tissue recovery after acute myocardial infarction?
    Faxon DP
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):14-5. PubMed ID: 16265251
    [No Abstract]   [Full Text] [Related]  

  • 19. Modern drug treatment--No. 8. Drugs and the prevention of death from myocardial infarction.
    Graham IM
    Ir Med J; 1982 Aug; 75(8):291-6. PubMed ID: 6127329
    [No Abstract]   [Full Text] [Related]  

  • 20. Reappraisal of beta-blocker therapy in the acute and chronic post-myocardial infarction period.
    Borrello F; Beahan M; Klein L; Gheorghiade M
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S13-24. PubMed ID: 14564230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.